Insider · CIK 0001982278
Nir Naor
Files at AXGN (Axogen, Inc.), BCLI (BRAINSTORM CELL THERAPEUTICS INC.), STIM (Neuronetics, Inc.). First filing -, latest -.
In brief
Nir Naor files SEC Form 4 as CFO and director at AXGN (Axogen, Inc.), and also at BCLI (BRAINSTORM CELL THERAPEUTICS INC.), STIM (Neuronetics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Nir Naor has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | STIM Neuronetics, Inc. | AGrant or award Common Stock | +500,000 | $0.00 | $0 | 500,000 | Jul 23, 2026 |
| Feb 26, 2026 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | AGrant or award Stock Option (Right to Buy)derivative | +180,000 | $0.70 | $126k | 180,000 | May 20, 2026 |
| Jan 6, 2025 | AXGN Axogen, Inc. | FTax withholding Common Stock | -39,132 | $15.22 | $596k | 260,868 | Jan 6, 2025 |
| Jan 1, 2025 | BCLI BRAINSTORM CELL THERAPEUTICS INC. | AGrant or award Common Stock | +30,666 | $0.00 | $0 | 31,465 | Jan 3, 2025 |
Questions about Nir Naor
Answered from the filings on this page, as of the latest one.
Is Nir Naor buying or selling?
Nir Naor has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Nir Naor's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nir Naor has 0.
Where does Nir Naor file Form 4?
Nir Naor has filed Form 4 at AXGN (Axogen, Inc.) as CFO; BCLI (BRAINSTORM CELL THERAPEUTICS INC.); STIM (Neuronetics, Inc.) as EVP, CFO & Treasurer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.